Evidence map›Paper›PMID 32404939›Full record

ArticleScientific reports2020

The early local and systemic Type I interferon responses to ultraviolet B light exposure are cGAS dependent.

Sladjana Skopelja-Gardner, Jie An, Joyce Tai, Lena Tanaka, Xizhang Sun, Payton Hermanson, Rebecca Baum, Masaoki Kawasumi, Richard Green, Michael Gale and 3 more

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 76 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
76citing papers in PubMed, 1 pooled it
4.0field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

76 citing papers in PubMed, 1 synthesis or guideline pooled it, 111 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Endothelial cell expression of STINGThe Journal of investigative dermatology · 2026
    Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Review
  16. Article
  17. Article
  18. Review
  19. Article
  20. Article

16 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 3 institutions in 1 country.

Sladjana Skopelja-GardnerDivision of Rheumatology, University of Washington, Seattle, WA, USA. ssg12@uw.edu.
Jie AnDivision of Rheumatology, University of Washington, Seattle, WA, USA.
Joyce TaiDivision of Rheumatology, University of Washington, Seattle, WA, USA.
Lena TanakaDivision of Rheumatology, University of Washington, Seattle, WA, USA.
Xizhang SunDivision of Rheumatology, University of Washington, Seattle, WA, USA.
Payton HermansonDivision of Rheumatology, University of Washington, Seattle, WA, USA.
Rebecca BaumDivision of Rheumatology, University of Washington, Seattle, WA, USA.
Masaoki KawasumiDivision of Dermatology, University of Washington, Seattle, WA, USA.
Richard GreenDepartment of Immunology, University of Washington, Seattle, WA, USA.
Michael GaleDepartment of Immunology, University of Washington, Seattle, WA, USA.
Andrea KalusDivision of Dermatology, University of Washington, Seattle, WA, USA.
Victoria P WerthDermatology Section, Philadelphia Veterans Affairs Medical Center, Philadelphia, USA.
Keith B ElkonDivision of Rheumatology, University of Washington, Seattle, WA, USA. KElkon@medicine.washington.edu.
University of Washington · USAlpine Immune Sciences (United States) · USVeterans Health Administration · US

Funding

XENOBIOTIC BIOTRANSFORMATION AND DISPOSITIONP30ES007033 · NIEHS · UNIVERSITY OF WASHINGTON · PI Sheela Sathyanarayana · 1995 to 2026
$42.5M
RESEARCH TRAINING IN RHEUMATOLOGYT32AR007108 · NIAMS · UNIVERSITY OF WASHINGTON · PI Shaun Jackson, Tomas M Mustelin · 1986 to 2026
$6.6M
Optimization of Clinical Trial Design in Cutaneous LupusR01AR071653 · NIAMS · UT SOUTHWESTERN MEDICAL CENTER · PI CHONG, BENJAMIN FRANKLIN, WERTH, VICTORIA P · 2018 to 2020
$653k
Link between Retroelements, Ro and Interferon Biology in LupusR21AR072377 · NIAMS · UNIVERSITY OF WASHINGTON · PI ELKON, KEITH B. · 2017 to 2018
$426k
Mechanisms of end organ damage in novel polygenic lupus modelsR56AR073848 · NIAMS · UNIVERSITY OF WASHINGTON · PI ELKON, KEITH B. · 2019 to 2019
$405k
The role of TNF-Alpha in cutaneous integrityI01BX000706 · VA · PHILADELPHIA VA MEDICAL CENTER · PI WERTH, VICTORIA P · 2013 to 2016
–
BLRD VA I01 BX000706NIAMS NIH HHS R01 AR071653NIAMS NIH HHS R21 AR072377NIAMS NIH HHS R56 AR073848NIAMS NIH HHS T32 AR007108NIEHS NIH HHS P30 ES007033
6 · The paper itself

Abstract

Most systemic lupus erythematosus (SLE) patients are photosensitive and ultraviolet B light (UVB) exposure worsens cutaneous disease and precipitates systemic flares of disease. The pathogenic link between skin disease and systemic exacerbations in SLE remains elusive. In an acute model of UVB-triggered inflammation, we observed that a single UV exposure triggered a striking IFN-I signature not only in the skin, but also in the blood and kidneys. The early IFN-I signature was significantly higher in female compared to male mice. The early IFN-I response in the skin was almost entirely, and in the blood partly, dependent on the presence of cGAS, as was skin inflammatory cell infiltration. Inhibition of cGAMP hydrolysis augmented the UVB-triggered IFN-I response. UVB skin exposure leads to cGAS-activation and both local and systemic IFN-I signature and could contribute to acute flares of disease in susceptible subjects such as patients with SLE.

Indexed as

Environmental ExposureAnimalsCyclic Guanosine Monophosphate-Adenosine Monophosphate SynthaseCytokinesDermatitisDisease Models, AnimalDisease SusceptibilityFemaleHumansInflammation MediatorsInterferon Type IMaleMiceMice, KnockoutNucleotidyltransferasesSex FactorscGAS protein, humanCyclic Guanosine Monophosphate-Adenosine Monophosphate SynthaseCytokinesInflammation MediatorsInterferon Type INucleotidyltransferases

Identifiers

PMID32404939
PMCPMC7220927
OpenAlexW3025562947

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.